This is an economic evaluation that meets the criteria for inclusion on NHS EED.
Location/setting
USA/hospital.
Methods

Analytical approach:
Two stochastic models were constructed to simulate the two risk scenarios, in a 750-bed facility. An alternative scenario allowed contamination from surfaces, and a secondary analysis explored the impact of increased compliance, in a 200-bed facility. The authors stated that they included the costs from the hospital perspective.
Effectiveness data:
The key clinical data were the probabilities of MRSA transmission from the first patient to the health care worker, and from the health care worker to the second patient. These values were derived using data from the Duke University Medical Center, a 750-bed, tertiary care, hospital in North Carolina, and published reports. The final projected mean number of MRSA infections per contaminated event (0.001) was derived by incorporating a range of clinical inputs, including the probability of each patient being initially MRSA positive, the hospital length of stay, the number of daily room visits, the frequency of direct contact per visit, the incidence of hospital-acquired MRSA, and the hand hygiene compliance rate. If the health care worker complied with the hand hygiene guidelines, there was no infection transmission.
Monetary benefit and utility valuations:
Not applicable.
Measure of benefit:
The health benefit was measured by the number of hospital-acquired MRSA infections. 
Cost data:
The total hospital cost, for each hospital-acquired MRSA infection, was the median cost from a published report. The lower and upper limits of the identified published costs were used for the 5% to 95% confidence interval. The cost per infection was multiplied by the total number of infections, and then amortised over all one million noncompliant events, to calculate the mean cost per noncompliant event. Costs were reported in US $.
Analysis of uncertainty:
A probability distribution was assigned to the costs to reflect the uncertainty in this estimate. Confidence intervals were calculated for the mean costs, and interquartile ranges were calculated for the median costs.
Results
Over the million noncompliant events, the normal-risk scenario resulted in 42 MRSA infections ( The secondary analysis showed that, for a 200-bed facility, increasing hand hygiene compliance by 1% resulted in a decrease of annual noncompliance events by 20,046, preventing 0.84 MRSA infections, with a mean decrease in expected MRSA-related costs of $39,650 (95% CI 18,286 to 61,014).
A 5% improvement in compliance resulted in 4.21 MRSA infections prevented with a decrease in MRSA-related costs of $198,250 (95% CI 91,429 to 305,072).
